Maki Ando
Impact in
- Nephrology top 2%
- Renal Diseases and Glomerulopathies
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 10
- Lung Cancer Research Studies 4
- Neutropenia and Cancer Infections 4
- Cancer Treatment and Pharmacology 2
- Drug Transport and Resistance Mechanisms 2
-
- Cancer therapeutics and mechanisms 7
- Co-authors
- Yoshinori Hasegawa (11 shared papers)Yukio Ando (11 shared papers)Kaoru Shimokata (9 shared papers)Hideo Saka (6 shared papers)Soh Saitoh (1 shared paper)Hiroshi Ueoka (1 shared paper)Akira Yokoyama (1 shared paper)Toshiyuki Sawa (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Nephrology Dialysis Transplantation (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Pharmacogenetics and Genomics (1 paper)Respiration (1 paper)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Maki Ando
20 papers receiving 1.2k citations
Maki Ando's Hit Papers
Peers
Comparison fields: 5 of 75
- Nephrology 215
- Pharmacology 169
- Oncology 462
- Pediatrics, Perinatology and Child Health 187
- Molecular Biology 534
Countries citing papers authored by Maki Ando
This map shows the geographic impact of Maki Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maki Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maki Ando more than expected).
Fields of papers citing papers by Maki Ando
This network shows the impact of papers produced by Maki Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maki Ando. The network helps show where Maki Ando may publish in the future.
Co-authors
The 25 scholars most cited alongside Maki Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Hit paper breakdown → | 2000 | 608 |
| 2 | 2009 | 195 | |
| 3 | 2002 | 50 | |
| 4 | 2008 | 48 | |
| 5 | 2005 | 46 | |
| 6 | Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level. | 2000 | 38 |
| 7 | 2004 | 37 | |
| 8 | 2012 | 36 | |
| 9 | 2001 | 31 | |
| 10 | Pharmacological analysis of etoposide in elderly patients with lung cancer. | 1999 | 30 |
| 11 | 2005 | 21 | |
| 12 | 2005 | 11 | |
| 13 | 2006 | 10 | |
| 14 | 2014 | 9 | |
| 15 | 2004 | 9 | |
| 16 | 2004 | 8 | |
| 17 | 2001 | 8 | |
| 18 | 2009 | 3 | |
| 19 | 2011 | 2 | |
| 20 | 2022 | 1 |
About Maki Ando
Maki Ando is a scholar working on Oncology, Molecular Biology, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Surgery, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Neonatal Health and Biochemistry (5 papers), Lung Cancer Research Studies (4 papers), Neutropenia and Cancer Infections (4 papers), Lung Cancer Treatments and Mutations (3 papers), Renal Diseases and Glomerulopathies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Nephrology (215 citations), Pharmacology (169 citations), Oncology (462 citations), Pediatrics, Perinatology and Child Health (187 citations) and Molecular Biology (534 citations). Maki Ando has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Yoshinori Hasegawa, Yukio Ando, Kaoru Shimokata, Hideo Saka, Soh Saitoh, Hiroshi Ueoka, Akira Yokoyama, Toshiyuki Sawa, Kei Muro and Masaki Goto. Their work appears in journals such as Journal of Clinical Oncology, Nephrology Dialysis Transplantation, Cancer Chemotherapy and Pharmacology, Pharmacogenetics and Genomics and Respiration.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.